|
Apr 19
|
Is AbbVie Inc. (ABBV) the Best Pharma Stock to Buy for Long Term Growth?
|
|
Apr 18
|
Is AbbVie Inc. (ABBV) the Best Large-Cap Value Stock to Buy as the Recession Hits?
|
|
Apr 18
|
AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
|
Apr 18
|
Stocks to watch next week: Tesla, Alphabet, Intel, Boeing and Unilever
|
|
Apr 17
|
AbbVie Inc. (ABBV): Among the Innovative Healthcare Stocks to Watch in 2025
|
|
Apr 16
|
AbbVie Inc. (ABBV): One of the Best Dividend Monarchs to Invest in Now
|
|
Apr 16
|
Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks
|
|
Apr 16
|
The Zacks Analyst Blog AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment
|
|
Apr 15
|
Top Research Reports for AbbVie, TJX & Charles Schwab
|
|
Apr 15
|
AbbVie Inc. (ABBV): One of the High Growth Forever Dividend Stocks to Invest In
|
|
Apr 15
|
The Zacks Analyst Blog Merck and AbbVie
|
|
Apr 14
|
ABBV vs. MRK: Which Drug Giant is a Better Buy Now?
|
|
Apr 14
|
The Zacks Analyst Blog AbbVie's, Rinvoq and AstraZeneca's and Novartis
|
|
Apr 13
|
Is AbbVie Inc. (ABBV) the Best Stock for 15 Years?
|
|
Apr 8
|
AbbVie's Rinvoq Gets EU Nod for 8th Indication Giant Cell Arteritis
|
|
Apr 8
|
Goldman turns cautious on major pharma names, sees select upside at Eli Lilly
|
|
Apr 8
|
Should Schwab U.S. Dividend Equity ETF (SCHD) Be on Your Investing Radar?
|
|
Apr 8
|
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis
|
|
Apr 7
|
AbbVie (NYSE:ABBV) Showcases Cancer Treatment Advancements at AACR Annual Meeting
|
|
Apr 6
|
3 Dividend Stocks to Buy and Hold for the Next Decade
|